Qyuns Therapeutics Co., Ltd.

Qyuns Therapeutics Co., Ltd.verified

2509.HK

Price:

$20.46

Market Cap:

$4.13B

Qyuns Therapeutics Co., Ltd., a clinical-stage biotech company, focuses on the research and development of biologic therapies for autoimmune and allergic diseases in the People's Republic of China. The company's lead product candidates include QX002N, an interleukin (IL)-17A inhibitor in Phase III clinical trial for the treatment of ankylosing spondylitis and lupus nephritis; and QX005N, a monoclonal antibody (mAb) blocking IL-4Ra, which has completed Phase II clinical trial, to treat atopic dermatitis, prurigo nodularis, chronic rhinosinusitis with nasal polyps, chronic spontaneous urticaria (CSU), asthma, and chronic obstructive pulmonary disease (COPD). It also develops QX001S, an IL-12/I...[Read more]

Industry

Biotechnology

IPO Date

Stock Exchange

HKSE

Ticker

2509.HK

The ROE as of December 2025 (TTM) for Qyuns Therapeutics Co., Ltd. (2509.HK) is -84.24%

According to Qyuns Therapeutics Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -84.24%. This represents a change of 301.62% compared to the average of -20.98% of the last 4 quarters.

Qyuns Therapeutics Co., Ltd. (2509.HK) Historical ROE (quarterly & annually)

How has 2509.HK ROE performed in the past?

The mean historical ROE of Qyuns Therapeutics Co., Ltd. over the last ten years is -102.70%. The current -84.24% ROE has changed -17.97% with respect to the historical average. Over the past ten years (40 quarters), 2509.HK's ROE was at its highest in in the June 2023 quarter at 0%. The ROE was at its lowest in in the December 2023 quarter at -45.38%.

Quarterly (TTM)
Annual

Average

-102.70%

Median

-103.94%

Minimum

-156.45%

Maximum

-46.47%

Qyuns Therapeutics Co., Ltd. (2509.HK) ROE by Quarter and Year

Discovering the peaks and valleys of Qyuns Therapeutics Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 236.69%

Maximum Annual ROE = -46.47%

Minimum Annual Increase = -24.22%

Minimum Annual ROE = -156.45%

Quarterly (TTM)
Annual
YearROEChange
2024-146.55%-6.33%
2023-156.45%236.69%
2022-46.47%-24.22%

Qyuns Therapeutics Co., Ltd. (2509.HK) Average ROE

How has 2509.HK ROE performed in the past?

The current ROE of Qyuns Therapeutics Co., Ltd. (2509.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-116.49%

5-year avg

-102.70%

10-year avg

-102.70%

Qyuns Therapeutics Co., Ltd. (2509.HK) ROE vs. Peers

How is 2509.HK’s ROE compared to its peers?

Qyuns Therapeutics Co., Ltd.’s ROE is greater than AIM Vaccine Co., Ltd. (-8.07%), less than Viva Biotech Holdings (4.48%), greater than Jacobio Pharmaceuticals Group Co., Ltd. (-5.10%), greater than Ocumension Therapeutics (-6.71%), less than Medtide Inc. (0%), less than TYK Medicines, Inc (153.33%), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (-49.89%), greater than Antengene Corporation Limited (-28.27%), less than Shanghai Kindly Medical Instruments Co., Ltd. (10.41%), less than Modern Dental Group Limited (16.76%),

Build a custom stock screener for Qyuns Therapeutics Co., Ltd. (2509.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Qyuns Therapeutics Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Qyuns Therapeutics Co., Ltd. (2509.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Qyuns Therapeutics Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Qyuns Therapeutics Co., Ltd.'s ROE?

How is the ROE calculated for Qyuns Therapeutics Co., Ltd. (2509.HK)?

What is the highest ROE for Qyuns Therapeutics Co., Ltd. (2509.HK)?

What is the 3-year average ROE for Qyuns Therapeutics Co., Ltd. (2509.HK)?

What is the 5-year average ROE for Qyuns Therapeutics Co., Ltd. (2509.HK)?

How does the current ROE for Qyuns Therapeutics Co., Ltd. (2509.HK) compare to its historical average?